Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcomaMichael Roth, Richard Görlick, David S. Geller et al.|Cancer|2013Cited by 157
Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in OsteosarcomaYu Cao, Richard Görlick, E. Anders Kolb et al.|PLoS ONE|2014Cited by 47